TheBateman schreef op 14 juli 2016 10:39:
Uit de filling:
Taking into consideration a target population as described above (approximately 72,000 patients in Europe and approximately 46,000 patients in the United States) and assuming a sales price of $25,000, we estimate Cx601's potential market opportunity to be approximately $2.95 billion for Europe and the United States combined.